McDermott Paris and US corporate and antitrust lawyers were counsel to French company Bioprojet SCR in structuring a collaborative agreement that gave biopharmaceutical company Harmony Biosciences the exclusive US right to develop, register and market a drug to treat adults suffering from narcolepsy.